MetaADEDB 2.0 @ LMMD
Arterial Injury
(UMLS:C0340652)
UMLS ID:
C0340652
MeSH ID:
N/A
Synonym(s)
1.
Arterial Injury
2.
Arterial injury
3.
Arterial injury, NOS
4.
Injury of artery
5.
Injury of artery, NOS
6.
arterial injuries
7.
arterial injury
8.
arteries injury
9.
artery injuries
10.
artery injury
11.
artery; injury
12.
injury; artery
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1rofecoxibFAERS: 11OFFSIDES
US FAERS
2AlendronateFAERS: 4US FAERS
3WarfarinFAERS: 4US FAERS
4AspirinFAERS: 3US FAERS
5DabigatranFAERS: 3US FAERS
6RivaroxabanFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
7RosiglitazoneFAERS: 3US FAERS
8apixabanFAERS: 3US FAERS
9etonogestrelFAERS: 3US FAERS
10BromocriptineFAERS: 2US FAERS
11Duloxetine HydrochlorideFAERS: 2US FAERS
12GoserelinFAERS: 2US FAERS
13LCZ 696FAERS: 2US FAERS
14LidocaineFAERS: 2US FAERS
15NaproxenFAERS: 2US FAERS
16RanolazineFAERS: 2US FAERS
17TacrolimusFAERS: 2US FAERS
18TeriparatideFAERS: 2US FAERS
19Zoledronic AcidFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
20ambrisentanFAERS: 2US FAERS
21gemcitabineFAERS: 2US FAERS
22macitentanFAERS: 2US FAERS
23reviparinFAERS: 2US FAERS
24valdecoxibFAERS: 2US FAERS
252-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chlorideFAERS: 1US FAERS
264-hydroxybutyric acidFAERS: 1US FAERS
274-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamideFAERS: 1US FAERS
28Adzenys XR-ODTFAERS: 1US FAERS
29Aspirin-oxycodone hydrochloride-oxycodone terephthalate combinationFAERS: 1US FAERS
30BupivacaineFAERS: 1US FAERS
31BusulfanFAERS: 1US FAERS
32Deoxycholic AcidFAERS: 1US FAERS
33Dimethyl FumarateFAERS: 1US FAERS
34DocetaxelFAERS: 1US FAERS
35Fingolimod HydrochlorideFAERS: 1US FAERS
36Gadolinium DTPAFAERS: 1US FAERS
37Glatiramer AcetateFAERS: 1US FAERS
38InsulinFAERS: 1US FAERS
39Iothalamate MeglumineFAERS: 1US FAERS
40Lisdexamfetamine DimesylateFAERS: 1US FAERS
41MethamphetamineFAERS: 1US FAERS
42Methylprednisolone HemisuccinateFAERS: 1US FAERS
43MetoprololFAERS: 1US FAERS
44MitoxantroneFAERS: 1US FAERS
45Mycophenolic AcidFAERS: 1US FAERS
46NorgestrelFAERS: 1US FAERS
47OlanzapineFAERS: 1US FAERS
48OmeprazoleFAERS: 1US FAERS
49PentazocineFAERS: 1US FAERS
50Potassium ChlorideFAERS: 1US FAERS
51Prasugrel HydrochlorideFAERS: 1US FAERS
52PregabalinFAERS: 1US FAERS
53SimvastatinFAERS: 1US FAERS
54SpironolactoneFAERS: 1US FAERS
55SunitinibFAERS: 1US FAERS
56TinzaparinFAERS: 1US FAERS
57ValsartanFAERS: 1US FAERS
58VareniclineFAERS: 1US FAERS
59acetaminophen, aspirin, caffeine drug combinationFAERS: 1US FAERS
60drospirenone and ethinyl estradiol combinationFAERS: 1US FAERS
61eicosapentaenoic acid ethyl esterFAERS: 1US FAERS
62liposomal amphotericin BFAERS: 1US FAERS
63liposomal doxorubicinFAERS: 1US FAERS
64testosterone 17 beta-cypionateFAERS: 1US FAERS
65BeclomethasoneOFFSIDES
66BeclomethasoneOFFSIDES
67BisacodylOFFSIDES
68BortezomibOFFSIDES
69BromocriptineOFFSIDES
70BupropionOFFSIDES
71ChlorprothixeneOFFSIDES
72DidanosineOFFSIDES
73DipyroneOFFSIDES
74FinasterideOFFSIDES
75KetorolacOFFSIDES
76Ketorolac TromethamineOFFSIDES
77MethocarbamolOFFSIDES
78Mometasone FuroateOFFSIDES
79OctreotideCanada Vigilance: 1Canada Vigilance
80RamiprilOFFSIDES
81SumatriptanOFFSIDES
82TirofibanOFFSIDES
83Tolterodine TartrateOFFSIDES
84TopotecanOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.